Share
18,457 Posts.
lightbulb Created with Sketch. 3841
clock Created with Sketch. 02/06/20
14:34
Share
Originally posted by SaltySultana
↑
The patent expiries are positive for OPT. Essentially the owners of Lucentis or Eylea can sell these drugs in combination with OPT. This allows them to protect their existing sales, despite them coming off patent. OPT's key patents extend to 2034.
Expand
I just found your useful post of February 26 Salty...https://hotcopper.com.au/posts/43157676/single
Originally posted by SaltySultana
↑
Key points from webcast Q&A:
Expand
That some of the patents will be coming off just as Opthea has its results in sounds very positive as long as the results are goodhttps://hotcopper.com.au/documentdownload?id=uOMxKKzFkiWRTLKhOROKAxjvSTYP4Au8yBeZr+dtke92GA==
Last edited by
sabine :
02/06/20
(20min delay)